5-Hydroxytryptamine (5-HT) 3 receptor (5-HT 3 R) antagonists are effective in treating patients with irritable bowel syndrome (IBS) and have anxiolytic effects. Their therapeutic effects are related, in part, to reducing amygdala engagement during expected visceral pain. A single nucleotide polymorphism in HTR3A, c.-42CϾT;(C178T; rs1062613), is associated with altered reactivity of the amygdala during emotional face processing in healthy subjects (controls). We evaluated the influence of this single nucleotide polymorphism on amygdala reactivity to emotional faces and nonemotional stimuli in female patients with IBS and controls. METH-ODS: We measured brain responses during an affectmatching paradigm in 54 women (26 with IBS, 29 controls) using functional magnetic resonance imaging. We examined associations between HTR3A c.-42CϾT genotype (C/C vs T carrier) and responses in amygdala and other regions of brain that expressed high levels of 5-HT 3 R. RESULTS: The C/C genotype was associated with greater anxiety symptoms in patients with IBS and controls and increased activation of the amygdala under emotional and nonemotional conditions. Among patients with IBS, C/C genotype was associated with greater symptom ratings. A subset of IBS patients with the C/C genotype had increased amygdala responses to nonemotional stimuli, compared with other subjects with C/C genotype. CONCLUSIONS: Regardless of diagnosis, the C/C genotype of the c.-42C>T polymorphism in HTR3A, compared with T carrier status, is associated with increased anxiety and amygdala responsiveness during emotional and nonemotional tasks. This polymorphism was associated with severity of IBS symptoms. Although this genotype is not sufficient for diagnosis of IBS, it is associated with severity of symptoms.
P reclinical and clinical evidence supports an important role of the serotonin (5-hydroxytryptamine [5- HT]) signaling system in the modulation of the brain gut axis, and alterations in this signaling system may play a role in functional gastrointestinal disorders such as irritable bowel syndrome (IBS), 1 psychiatric disorders (anxiety, depression, and eating disorders 2 ), and pregnancyrelated nausea. 3 5-HT 3 R antagonists are one of the most effective treatments for patients with diarrhea-predominant IBS (IBS-D) 4 -6 and also have shown effectiveness in comorbid chronic pain disorders, including functional dyspepsia and fibromyalgia. 7 Several clinical studies reported beneficial effects of 5-HT 3 R antagonists in the treatment of anxiety, 8 which is highly comorbid with IBS, eating disorders, and fibromyalgia. 9 Animal studies support the concept that 5-HT 3 R antagonists have anxiolytic effects by attenuating the response of emotional arousal circuits in the brain. 10 -12 Even though the precise mechanism(s) underlying the effectiveness of the most widely tested 5-HT 3 R antagonists (alosetron, cilansetron) in treating IBS-D symptoms remain incompletely understood, evidence supports both peripheral and central mechanisms of action. 4 For example, symptom improvement during alosetron treatment was associated with a reduction in amygdala activity during anticipation of abdominal pain, 13 consistent with a possible role of increased activity of amygdala-related emotional arousal circuits in the pathophysiology of IBS. 14 5-HT 3 Rs are widely distributed in the central and peripheral nervous systems, including the enteric nervous system. 15, 16 Within the central nervous system, 5-HT 3 Rs are found in amygdala, hippocampus, cingulate cortex, striatum, entorhinal frontal cortex, as well as brainstem and the superficial layers of the spinal cord. [17] [18] [19] Rs are unique, representing the only ligand-gated cation Abbreviations used in this paper: BA, Brodmann Area; fMRI, functional magnetic resonance image; GABA, ␥-aminobutyric acid; HC, healthy controls; 5-HT, 5-hydroxytryptamine; IBS, irritable bowel syndrome; IBS-D, diarrhea-predominant irritable bowel syndrome; ME, match emotion; MF, match forms; PFC, prefrontal cortex; ROI, region of interest; SNP, single nucleotide polymorphism; SVC, small volume correction.
© 2011 by the AGA Institute 0016-5085/$36.00 doi:10.1053/j.gastro.2011.03.011 channel among 5-HT receptors, which are primarily expressed presynaptically. 20, 21 The presynaptic expression of 5-HT 3 Rs on nerve endings is consistent with their physiological role in the release of neurotransmitters such as dopamine, cholecystokinin, glutamate, acetylcholine, and ␥-aminobutyric acid (GABA). 22 Consequently, both excitatory and inhibitory effects of 5-HT 3 R activation have been reported that may be mediated by activation of excitatory and inhibitory interneurons, respectively. 23 For example, 5-HT 3 R activation on GABAergic interneurons innervating the amygdala exert an inhibitory influence on amygdala activity, whereas those on excitatory glutaminergic interneurons have the opposite effect 23 (Figure 1 ).
There is considerable molecular diversity within the 5-HT 3 R family resulting from variable composition of 5 different subunits (5-HT 3A-E ), with differential expression of subunits in different regions of the nervous system. 23 Several polymorphisms of the 5-HT 3A R, 5-HT 3B R, 5-HT 3C R, and 5-HT 3E R encoding genes (HTR3A, B, C, and E) have been reported to be associated with gastrointestinal disorders (including IBS), 24 pregnancy-related nausea, 3 and several psychiatric conditions (including anxiety, depression, and eating disorders). 2, 25, 26 For example, the novel HTR3E 3=-untranslated region variant c.*76GϾ A has been shown to be associated with a diagnosis of IBS-D in female patients in two independent samples, suggesting a possible role of this variant in intestinal fluid handling. 24 The relatively common variant c.-42CϾT (minor allele frequency, 0.15-0.23) within the 5= untranslated region of the HTR3A gene is associated with increased 5-HT 3A subunit expression in vitro. 24, 26 The less common T allele, vs the C allele, is associated with reduced amygdala and prefrontal cortical activation during a face-recognition task and may be associated with the personality trait of lower harm avoidance in women. 27, 28 These findings are consistent with T-allele-related increased expression of 5-HT 3 Rs on inhibitory GABAergic interneurons, resulting in greater inhibition of the amygdala.
We aimed to examine, in female IBS patients and healthy controls (HCs), the impact of HTR3A c.-42CϾT on responses in 5-HT 3 R-rich brain regions during an affect-matching paradigm known to reliably activate the amygdala. 29 Based on the evidence summarized earlier, and the concept of increased engagement of amygdalarelated emotional arousal circuits in IBS pathophysiology, 14 our main hypothesis was that subjects carrying the C/C genotype of the HTR3A single nucleotide polymorphism (SNP) c.-42CϾT would show greater responses of the amygdala, and possibly greater IBS severity.
Materials and Methods Subjects
A sample of 26 female IBS patients and 29 female healthy controls (demographics are presented in Table 1 ) participated in functional magnetic resonance image (fMRI) studies of emotional reactivity and provided saliva samples for DNA analyses. Subjects were recruited through the University of California Los Angeles Digestive Disease Clinic and from community advertisements. The diagnosis of IBS was confirmed using Rome II criteria during a clinical examination by a gastroenterologist or nurse practitioner experienced in functional gastrointestinal disorders. 30 Nineteen percent of IBS patients rated their usual symptoms as moderate (cannot be ignored but does not affect your lifestyle), 62% as severe (affects your lifestyle), and 19% as very severe (markedly affects your lifestyle). Control subjects received medical examinations to confirm absence of functional pain disorders. All subjects were free of current or past psychiatric illness, substance abuse disorder, and major medical or neurologic conditions. No subjects took medications for 30 days before scanning. The University of California Los Angeles Institutional Review Board approved all studies; informed consent was obtained from all subjects.
Genotyping
DNA was extracted at the University of California Los Angeles Biological Samples Processing Core. Samples for DNA isolation were collected using the Oragene DNA Self-Collection Kit (DNA Genotek, Inc, Ottawa, Canada). DNA obtained using this kit is comparable in quality and quantity with DNA extracted from blood. 31 SNP genotyping was performed with the KASPar assay system (KBiosciences, Ltd, Hoddesdon, UK) as recommended by the manufacturer. The primers used for HTR3A c.-42CϾT were as follows: rs1062613_ALC: 5=-GAAGGT-GACCAAGTTCATGCTGCCTCCGAGTGCTCAGGG-3=; rs1062613_ALT: 5=-GAAGGTCGGAGTCAACGGATT-GTGCCTCCGAGTGCTCAGGA-3=; and rs1062613_C1: 5=-AGGTTGGCAGAGGGCAGGCAA-3=. An initial 15-minute cycle at 94°C was followed by 20 cycles consisting of 10 seconds at 94°C, 5 seconds at 57°C, and 10 seconds at 72°C; 23 cycles consisting of 10 seconds at 94°C, 20 seconds at 57°C, and 40 seconds at 72°C; and a cool down at 10°C. After the thermal cycling, results were analyzed using the fluorescence plate reader TaqMan 7500 system (Applied Biosystems, Foster City, CA).
Study Design
Before scanning, IBS patients rated the following: (1) overall severity of their gastrointestinal symptoms, (2) severity of abdominal pain, and (3) severity of bloating on a numeric rating scale of 0 (no symptoms) to 20 (the most intense symptoms imaginable). All subjects completed the Hospital Anxiety and Depression scale, a measure of current anxiety symptoms validated for nonpsychiatric samples. 32 Subjects completed 2 runs of an emotional reactivity task (adapted from Hariri et al 29 ) consisting of 2 conditions: match emotion (ME) and match forms (MF). During the ME condition, subjects viewed a target face 33 depicting an angry or fearful expression and were asked to select 1 of 2 other faces that expressed the same emotion. In the ME task, subjects tend to match the emotional faces based on perceptual characteristics, such as a furrowed brow. 29 The MF condition is a neutral control task in which subjects perform a similar perceptual decision (match forms), but no emotional stimuli are presented. During the MF condition, subjects viewed a circular-shaped target (approximately the same size as a human face) and were asked to select 1 of 2 other shapes that best matched the target. Traditionally, the difference in activity during the emotional condition compared with the neutral condition (MEϪMF) has been considered a measure of emotional reactivity. 29 Stimuli were presented in randomized sequences, counterbalanced across runs. Each condition was presented as a block of 6 images, with each image presented for 3 seconds, for a total block length of 18 seconds. In each run, 4 blocks of ME and 4 blocks of MFs were presented randomly. Subjects completed 2 runs, thus a total of 48 images were presented in the ME condition and 48 images were presented in the MF condition. An instruction cue was presented for 3 seconds before each block and a rest period of 6 seconds followed each block. Subjects were presented with additional facial stimuli as part of an emotional modulation task; however, the current study involves the results of the emotional reactivity task only.
fMRI Procedures
fMRI was performed using a 3.0-T MRI scanner (Siemens Trio; Siemens, Erlangen, Germany). A highresolution structural image was acquired from each subject with a magnetization-prepared rapid acquisition gradient-echo sequence, repetition time of 2300 ms, echo time of 2.85 ms, 256 slices, 160*240 matrix, 1 3 mm voxel size. Functional blood oxygen-level dependent images were acquired (repetition time of 3000 ms, echo time of 28 ms, flip angle of 90°, 38 slices, slice thickness of 3 mm) while subjects completed 2 runs of the emotional reactivity task. Stimuli were presented via MRI-compatible goggles using Superlab 4.0 software (Cedrus Corp, San Pedro, CA). Subjects responded using an MRI-compatible button box by pressing 1 of 2 buttons with the right hand.
Data Analysis
The first 2 volumes were discarded to allow for stabilization of the magnetic field. The remaining functional images were slice-time-and motion corrected, spatially normalized to the Montreal Neurological Institute (MNI) template, and spatially smoothed with a 8-mm 3 Gaussian kernel using SPM5 (Welcome Department of Cognitive Neurology, London, UK). Although the amygdala was the primary region of interest (ROI), additional ROIs were chosen a priori and consisted of brain areas previously associated with 5-HT 3 R distribution. [17] [18] [19] ROIs for the amygdala, caudate, hippocampus, insula, anterior cingulate, and medial prefrontal cortex (PFC) were created using the Wake Forest University (WinstonSalem, North Carolina) PickAtlas toolbox in SPM5. 34 -37 Functional data were analyzed using the general linear model within SPM5. For each individual subject, fixedeffect analyses were performed comparing the following: (1) ME vs an implicit baseline, (2) MF vs an implicit baseline, and (3) ME vs MF (ME-MF). Parameter estimates for ME-MF were considered a measure of emotional reactivity. 29 We included analyses of brain responses during ME and MF conditions (considered individually) to provide additional information on potential group differences in the specificity of brain responsiveness. Random-effect analyses were performed to examine genotype and diagnosis effects with age of the subject entered as a covariate. Small volume correction (SVC) for ROIs was applied using SPM5 family-wise error algorithm and a volume-corrected probability value of less than 0.05 was considered significant. A priori power analyses conducted in G*Power 3.1.2 (www.psycho. uni-duesseldorf.de/aap/projects/gpower/) indicated that 10 subjects per group were required to provide adequate power (1 -␤ ϭ 0.80) to detect an effect size difference (d ϭ 1.20, z ϭ 2.4) in brain activity commonly seen in our research studies, using a one-sample t test.
The association of genotype with diagnosis was analyzed by chi-square and risk assessment tests; the genetic impact on anxiety and symptom ratings was analyzed by analysis of variance using PASW 17 (SPSS, Inc; Chicago, IL).
Results

Clinical Characteristics
HTR3A polymorphism. Fifteen of 29 HCs and 16 of 26 IBS patients were homozygous for the C allele, 9 HCs and 7 patients carried the heterozygous C/T genotype, and 5 HCs and 3 patients carried the homozygous T/T genotype. The c.-42CϾT SNP had been found previously to be associated with IBS-D in a UK sample applying a minor allele dominant model. 24 Thus, subjects carrying a T allele (C/T or T/T) were combined into a single group (T carriers) for analyses.
A HTR3A genotype (C/C, T carrier) ϫ diagnosis (HC, IBS) analysis of variance revealed a significant interaction of diagnosis and T-carrier status on anxiety symptoms, with IBS patients reporting higher anxiety ratings, and T carriers (IBS and HCs combined) reporting lower anxiety ratings (F(1,51) ϭ 4.20, P ϭ .046; F(1,51) ϭ 4.37, P ϭ .042, respectively). Among IBS patients, T carriers had significantly lower overall symptom severity and abdominal discomfort (bloating) ratings (t(24) ϭ 2.102, P ϭ .046, t(24) ϭ 2.654, P ϭ .014, respectively). However, T carriers with IBS did not differ in abdominal pain ratings (P Ͼ .05). Means and standard errors are displayed in Table 1 . Chi-square tests and risk estimates indicated no significant association between T-carrier status and IBS diagnosis (P Ͼ .05).
Emotional Reactivity (ME-MF) at the Whole Brain Level
Activity during ME relative to MF (ME-MF; with age entered as a covariate) was first examined at the whole brain level to determine if regions differentially activated in response to emotional faces compared with neutral visual stimuli were similar to previous studies of emotional reactivity. Areas that were significantly activated (P Ͻ .05, family-wise error, extent Ն 30 voxels) across all subjects included right amygdala, bilateral visual cortex ( Table 2 ). Areas that were significantly deactivated (P Ͻ .05, family-wise error, extent Ն 30 voxels) during ME relative to MF included bilateral medial PFC (BA 24/32), bilateral insula, bilateral posterior cingulate cortex (BA 23/31), and left BA 39 ( Table 2) . These results are consistent with previous studies using a similar emotional reactivity paradigm. 29, 38 
HTR3A Effects on Brain Responses in Specific Regions
An ROI analysis was conducted to examine diagnosis and HTR3A genotype effects on activity of the amygdala during a neutral visual control task (MF) and during an emotional task (ME) as well as effects on emotional reactivity (ME-MF). We hypothesized greater amygdala responses in C/C genotype subjects. In addition, we performed exploratory analyses of potential diagnosis and HTR3A genotype effects on activity of other 5-HT 3 R-rich brain regions.
MF. During MF, IBS subjects relative to HCs had significantly greater activity in the left amygdala whereas C/C genotype subjects (IBS and HCs combined) had greater activity in bilateral amygdala (Figure 2 ) relative to T carriers (Table 2 ; P Ͻ .05, SVC). No significant interactions in amygdala responses were found. Exploratory analyses showed significantly greater activity in the left caudate and hippocampus in IBS subjects relative to HCs and greater activity in the right hippocampus in C/C genotype subjects (IBS and HCs combined) relative to T carriers (Table 2 ; P Ͻ .05, SVC); however, only the left hippocampus remained formally significant with Bonferroni correction for multiple comparisons. ME. During ME, C/C genotype subjects (IBS and HCs combined) had greater activity in the right amygdala ( Figure 2 ; Table 2 ; P Ͻ .05, SVC). No significant diagnosis effects or interactions in amygdala responses were found. Exploratory analyses showed significantly greater activity in the left caudate and hippocampus of IBS subjects relative to HCs ( Figure 2 ; Table 2 ; P Ͻ .05, SVC), however, only the left hippocampus remained formally significant with Bonferroni correction for multiple comparisons. ME-MF. Although group differences existed in amygdala responses during ME and MF considered individually (see earlier), no significant group differences or interactions in amygdala emotional reactivity were found. Exploratory analyses showed that HCs relative to IBS patients had greater differential activity in the right insula during ME relative to MF condition (Table 2 ; P Ͻ .05, SVC). Also, T carriers relative to C/C genotype subjects (IBS and HCs combined) had greater differential activity in the left caudate and right hippocampus ( Table  2 ; P Ͻ .05, SVC). However, none of these results remained formally significant with Bonferroni correction for multiple comparisons.
Parameter estimates for emotional reactivity (ME-MF) of the right amygdala were extracted for each subject using the Marsbar toolbox (http://marsbar.sourceforge. net/). 39 As shown in Figure 3 , right amygdala reactivity estimates varied greatly among IBS patients with C/C genotype. Bartlett's test for homogeneity of variances showed significant differences in variance ( 2 (3) ϭ 9.62, P ϭ .022) such that IBS patients with C/C genotype had significantly more variance than IBS T carriers and HCs with C/C genotype ( 2 (1) ϭ 5.22, P ϭ .022; 2 (1) ϭ 6.58, P ϭ .01, respectively). The greater variance appeared to be owing to a subgroup of IBS patients with C/C genotype with unusually low differential activity during ME relative to MF. Therefore, additional analyses were performed to determine if this subgroup had higher amygdala responses during MF and/or lower amygdala responses during ME compared with other subjects with C/C genotype.
C/C genotype median split. An ROI analysis using a median split was performed, comparing IBS patients with C/C genotype and below median reactivity (IBS Low; n ϭ 8) with: (1) IBS patients with C/C genotype and above median reactivity (IBS High; n ϭ 8) and (2) HC with C/C genotype (n ϭ 15). Among subjects with C/C genotype, IBS subjects with low differential activity had significantly greater activity in the right amygdala during MF compared with both IBS and HCs with above median reactivity ( Table 2) . No significant differences were found during ME. Also, no significant differences between IBS patients with C/C genotype and above median reactivity and HC with C/C genotype were found. 
Discussion
We used a validated emotional reactivity paradigm to identify differences between IBS patients and HCs in emotional arousal-related brain responses. When contrasting the brain's response to the negative emotional faces with the response to neutral geometric forms (ME-MF), consistent activations in amygdala, thalamus, and lateral prefrontal and parietal cortices, and deactivations in medial PFC, insula, and posterior cingulate cortex were seen. C/C genotype, regardless of diagnosis, was associated with significantly greater anxiety and greater amygdala responses to emotional facial as well as neutral visual stimuli when brain responses during each condition were examined individually (ME and MF). In patients, the C/C genotype was associated with higher IBS symptom ratings, and a subset of IBS patients with C/C genotype had even greater amygdala responses during the neutral stimulus (eg, subjects with usually low differential activity during ME relative to MF), compared with other subjects with C/C genotype (eg, IBS/HC with a normal pattern of responses). Thus, even though the CC genotype conferred altered amygdala responsiveness and associated anxiety ratings across both IBS and HCs, there was also an interaction of this genotype with IBS diagnosis.
C/C genotype across groups showed greater amygdala responses to both emotional and nonemotional stimuli when compared with T carriers. This indiscriminate pattern of response suggests a generalized hyper-responsiveness of the amygdala in C/C genotype subjects. Indiscriminate or generalized increased amygdala responsiveness to emotional facial stimuli after acute experimental stress has been reported recently. 40 The investigators suggested that a shift of amygdala function occurred toward heightened sensitivity with lower levels of specificity, consistent with a state of hypervigilance under stress. Our findings suggest that the C/C genotype predisposes individuals to such indiscriminate hypervigilance. Consistent with this interpretation, Iidaka et al 28 showed increased amygdala and PFC responses to pictures of neutral faces (relative to pictures of houses) in HCs with C/C genotype compared with C/T genotype subjects. Despite a difference in paradigms, the current results are similar in that subjects with C/C genotype appear to be hyper-responsive to facial stimuli compared with T carriers. However, in the current study, subjects with C/C genotype were not specifically hyper-responsive to facial stimuli because they showed heightened amygdala responses when processing both emotional faces and nonemotional geometric forms. In other words, they showed a generalized amygdala hyper-responsiveness regardless of the emotional content of the images. Both HCs and IBS with the C/C genotype may have increased sustained or tonic activation of the amygdala, consistent with their greater anxiety symptoms relative to T-carrier subjects. Further analyses revealed a subgroup of IBS patients with C/C genotype that had unusually low differential amygdala activity during ME relative to MF (Figure 3 ). These subjects failed to discriminate between emotional and neutral stimuli owing to heightened amygdala responses during the nonemotional condition. These findings suggest an interaction between IBS diagnosis and C/C genotype. It remains to be determined if the unusual response pattern of the amygdala to neutral and emotional stimuli represents an endophenotype 41 that is associated with the HTR3A SNP, or perhaps is related to increased stress perceived by some IBS patients during the experiment.
The T allele is related to an increase of HTR3A expression compared with the C allele. 24, 26 Greater presynaptic expression of HTR3A on inhibitory GABAergic input to the amygdala is expected to result in greater GABAergic inhibition of the amygdala during serotonergic stimulation. 42, 43 Increased inhibitory GABAergic function in the amygdala via benzodiazepines, 44 microinfusion of GABA A -receptor agonists, 45 or neuron-rich grafts 46 has been associated with decreased anxiety. These results suggest T carriers have enhanced amygdala 5-HT 3A expression and GABAergic function associated with decreased anxiety. Both preclinical and clinical evidence supports a role for 5-HT 3 Rs in anxiety. For example, results from rodent studies have led to the consensus that 5-HT 3 R antagonists have anxiolytic effects by blocking limbic hyperactivity response. 10 -12 Clinical studies reported on beneficial effects of 5-HT 3 R antagonists in the treatment of anxiety. 47, 48 5-HT 3 R knockout mice have shown differences between sexes in 5-HT 3 regulation of depressionand anxiety-related behaviors. 49 Future studies will be required to determine if differences in sex exist in the association between C/C genotype and generalized amygdala responsiveness, anxiety, and IBS severity.
Limitations
IBS patient recruitment included all bowel habit types, and no relationship between bowel habit and genotype/amygdala response patterns was found in this relatively small sample (data not shown). Future studies with larger sample sizes for each bowel habit subtype are needed to adequately examine the specificity of the relationship between HTR3A c.-42CϾT polymorphism and amygdala responsiveness in terms of bowel habit.
Summary and Future Directions
By using a validated emotional reactivity paradigm, unrelated to the gastrointestinal system, we found significant correlations of the HTR3A c.-42CϾT polymorphism with amygdala responsiveness, anxiety, and IBS symptom severity in a relatively small sample. The study supports the important role of 5-HT 3 Rs in the modulation of emotional arousal circuits that previously have been shown to be related to 5-HT 3 R antagonist-mediated (alosetron) IBS symptom improvement. 13 These findings suggest that although this gene polymorphism is not essential for a diagnosis of IBS, it influences symptom severity via greater engagement of amygdala-related emotional arousal circuits. This is consistent with previous reports showing an important role of anxiety in symptom severity in IBS 50 and in functional dyspepsia. 51 The differential responsiveness of the amygdala based on genotype could underlie differences in responsiveness of individual IBS patients to 5-HT 3 R antagonists, as well as other centrally directed therapies. For example, only about 40% of patients were identified as responders in clinical trials with the 5-HT 3 R antagonist alosetron. 6 Alosetron's effectiveness in reducing symptoms in nonconstipated IBS patients has been associated with reduced amygdala responsiveness during nonaversive and aversive conditions. 13 The current study shows an effect of HTR3A c.-42CϾT polymorphism on amygdala reactivity to emotional and nonemotional stimuli. Additional research is needed to examine the relationship between emotional reactivity and visceral pain reactivity, and to directly examine the relationship between HTR3A c.-42CϾT polymorphism, amygdala reactivity, and response to 5-HT 3 R antagonists. Patients with C/C genotype appear to have up-regulated amygdala activity, thus they may be more resistant to treatment by 5-HT 3 R antagonists. 52 In general, subtyping of IBS patients based on gene variants of central receptors modulating emotional arousal may improve the outcome of future clinical trials.
